EMBL

Germany

Back to Profile

1-3 of 3 for EMBL Sort by
Query
Aggregations
Jurisdiction
        World 2
        Canada 1
IPC Class
C07C 11/00 - Acyclic unsaturated hydrocarbons 2
C07C 11/22 - Acyclic unsaturated hydrocarbons containing carbon-to-carbon triple bonds 2
C07K 14/00 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof 2
A61K 31/706 - Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom 1
A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca 1
See more
Found results for  patents

1.

USE OF 5-AZACYTIDINE TO INHIBIT NONSENSE-MEDIATED RNA DECAY (NMD)

      
Application Number EP2014059658
Publication Number 2014/180996
Status In Force
Filing Date 2014-05-12
Publication Date 2014-11-13
Owner
  • EMBL (Germany)
  • RUPRECHT-KARLS-UNIVERSITÄT HEIDELBERG (Germany)
Inventor
  • Bhuvanagiri, Madhuri
  • Hentze, Matthias
  • Lewis, Joe
  • Kulozik, Andreas

Abstract

The invention relates to the use of 5-azacytidine and pharmaceutically acceptable salts thereof in a method of treating or preventing diseases responsive to inhibition of nonsense-mediated mRNA decay, such as cystic fibrosis, muscular dystrophy, autosomal dominant polycystic kidney disease (ADOKD), ataxia telangiectasia, β039-thalassemia, cancer, factor VII deficiency, familial atrial fibrillation, hemophilia B, hepatic carnitine palmitoyltransferase 1A deficiency (CPT1A), heritable pulmonary arterial hypertension (HPAH), late infantile neuronal ceroid lipofuscinosis (LNCL), leukocyte adhesion deficiency I (LAD1 ), methylmalonic academia (MMA), Hurler syndrome, nephropatic cystinosis, obesity, peroxisome biogenesis disorder (PBD), renal tubular acidosis (RTA), retinitis pigmentosa (RP), Rett syndrome (RTT), spinal muscular atrophy (SMA), Stuve-Wiedemann syndrome (SMS), X-linked nephrogenic diabetes insipidus (XNDI), or Usher syndrome (USH 1 ).

IPC Classes  ?

  • A61K 31/706 - Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
  • A61K 45/06 - Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
  • A61P 21/00 - Drugs for disorders of the muscular or neuromuscular system

2.

UNNATURAL AMINO ACIDS COMPRISING A CYCLOOCTYNYL OR TRANS-CYCLOOCTENYL ANALOG GROUP AND USES THEREOF

      
Application Number EP2012051885
Publication Number 2012/104422
Status In Force
Filing Date 2012-02-03
Publication Date 2012-08-09
Owner EMBL (Germany)
Inventor
  • Lemke, Edward
  • Schultz, Carsten
  • Plass, Tilman
  • Milles, Sigrid
  • Koehler, Christine

Abstract

The present invention relates to unnatural amino acids comprising a cyclooctynyl or trans- cyclooctenyl analog group and having formula (I) or an acid or base addition salt thereof. The invention also relates to the use of said unnatural amino acids, kits and processes for preparation of polypeptides that comprise one or more than one cyclooctynyl or trans- cyclooctenyl analog group. These polypeptides can be covalently modified by in vitro or in vivo reaction with compounds comprising an azide, nitrile oxide, nitrone, diazocarbonyl or 1,2,4,5- tetrazine group.

IPC Classes  ?

  • C07K 14/00 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof
  • C07C 11/00 - Acyclic unsaturated hydrocarbons
  • C07C 11/22 - Acyclic unsaturated hydrocarbons containing carbon-to-carbon triple bonds

3.

UNNATURAL AMINO ACIDS COMPRISING A CYCLOOCTYNYL OR TRANS-CYCLOOCTENYL ANALOG GROUP AND USES THEREOF

      
Document Number 02826041
Status In Force
Filing Date 2012-02-03
Open to Public Date 2012-08-09
Grant Date 2020-07-07
Owner EMBL (Germany)
Inventor
  • Lemke, Edward
  • Schultz, Carsten
  • Plass, Tilman
  • Milles, Sigrid
  • Koehler, Christine

Abstract

The present invention relates to unnatural amino acids comprising a cyclooctynyl or trans- cyclooctenyl analog group and having formula (I) or an acid or base addition salt thereof. The invention also relates to the use of said unnatural amino acids, kits and processes for preparation of polypeptides that comprise one or more than one cyclooctynyl or trans- cyclooctenyl analog group. These polypeptides can be covalently modified by in vitro or in vivo reaction with compounds comprising an azide, nitrile oxide, nitrone, diazocarbonyl or 1,2,4,5- tetrazine group.

IPC Classes  ?

  • C07C 11/00 - Acyclic unsaturated hydrocarbons
  • C07C 11/22 - Acyclic unsaturated hydrocarbons containing carbon-to-carbon triple bonds
  • C07K 14/00 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof